Dave Muoio

athelets relaxing after jogging in the park

Photo by Violeta Stoimenova/Getty Images

By Dave Muoio 04:51 pm March 31, 2021
Published yesterday in PLoS ONE, the data suggests an alternative to the six-minute walk test often conducted in clinics to measure functional capacity.
Business people shaking hands in conference room

Photo by Martin Barraud/Getty Images

By Dave Muoio 02:18 pm March 31, 2021
The deal is valued at about $194 million and will drive about a third of the telemedicine company's expected revenue moving forward.
Abbott Virtual Clinic screenshot
By Dave Muoio 05:19 pm March 10, 2021
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.
MD Live screenshot
By Dave Muoio 03:35 pm February 26, 2021
Set to close in Q2, the deal will provide the payer's healthcare services subsidiary with an integrated virtual care offering.
Bundles of paper records
By Dave Muoio 03:32 pm February 26, 2021
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
Signing paperwork
By Dave Muoio 10:42 am February 10, 2021
Saykara's founder and team will be augmenting Nuance's R&D division.
Computer code
By Dave Muoio 10:34 am February 10, 2021
Thirty mobile health apps from larger healthcare information technology companies were susceptible to a broken object level authorization (BOLA) attack.
KardiaMobil 6L in use
By Dave Muoio 05:52 pm February 05, 2021
The company hopes that its more descriptive reports will distinguish the personal ECG offering from others limited to atrial fibrillation detection alone.
Screens from Apple's online and app-based COVID-19 symptom checker
By Dave Muoio 05:07 pm December 18, 2020
The tech company elaborated on its established digital health and wellness vision while improvising with the demands of an unexpected pandemic.
Lucira COVID test
By Dave Muoio 05:24 pm November 19, 2020
Lucira's molecular testing kit allows individuals to collect their own nasal sample and insert it into a device that provides results in under 30 minutes. The company is aiming to sell the single-use tests for roughly $50.

The Daily Brief Newsletter

Get daily news updates from Healthcare IT News.
Your subscription has been saved.
Something went wrong. Please try again.